• U.S. Stock Options With Biggest Changes in Implied Volatility
  • Canada Supreme Court Won’t Hear Eli Lilly Zyprexa Appeal
  • ThromboGenics Reports Jetrea Sales as Drug Fails Mid-Stage Study
  • Swiss Stocks Drop as Zurich Insurance Retreats on Profit
  • BlackRock Has Alternative to Money Funds: Credit Markets
  • DBV in Advanced Talks for U.S. Peanut Drug Partnership, CEO Says
  • Golden Parachutes Face Clampdown in EU Law on Executive Pay
  • Lundbeck Jumps as Depression Drug Gets Praise: Copenhagen Mover
  • Roche Experimental Leukemia Drug Helps Shrink Tumors
  • AstraZeneca Advances Three Cancer Drugs Into Late-Stage Trials
  • SAC Owes $549 Million for Elan Trades, Investors Say
  • AmEx, Merck Lead $16.5 Billion of Company Bond Issuance in U.S.
  • Chesapeake Partners Holdings in 1st Quarter: 13F Alert
  • Tudor Sells Stakes Apple, Emerging Markets Exchange Fund
  • Google’s Page Describes Speech Malady, Funds Research
« Previous 1 2 3 4 5 Next »